Invitation to second quarter and first half 2019 results presentation NewsKristin EivindvikAugust 20, 2019
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikJuly 22, 2019
Final confirmation of successful safety read-out in the Phase I Extension study NewsKristin EivindvikApril 8, 2019
Exercise of employee share options, mandatory notification of trade and resolution to increase share capital NewsKristin EivindvikFebruary 20, 2019
PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report NewsKristin EivindvikFebruary 6, 2019
Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer NewsKristin EivindvikDecember 20, 2018
